1. Pérez-Núñez, Iván, Rozalén, Catalina, Palomeque, José Ángel, Albanell, Joan, Celià-Terrassa, Toni. 2022. LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer. In Nature cancer, 3, 355-370. doi:10.1038/s43018-022-00339-4. https://pubmed.ncbi.nlm.nih.gov/35301507/
2. Selinger, Martin, Věchtová, Pavlína, Tykalová, Hana, Štěrba, Ján, Grubhoffer, Libor. 2022. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors. In Computational and structural biotechnology journal, 20, 2759-2777. doi:10.1016/j.csbj.2022.05.052. https://pubmed.ncbi.nlm.nih.gov/35685361/
3. Palijan, Ana, Fernandes, Isabelle, Verway, Mark, Mader, Sylvie, White, John H. 2009. Ligand-dependent corepressor LCoR is an attenuator of progesterone-regulated gene expression. In The Journal of biological chemistry, 284, 30275-87. doi:10.1074/jbc.M109.051201. https://pubmed.ncbi.nlm.nih.gov/19744932/